Sermorelin & GHRP-6 & GHRP-2 Blend – 9MG
Sermorelin & GHRP-6 & GHRP-2 Blend – 9MG is a research peptide combination containing 3mg Sermorelin, 3mg GHRP-6 and 3mg GHRP-2. The three peptides are studied in relation to growth hormone regulation through distinct receptor systems, making this blend relevant to laboratory research into pituitary signalling, somatotroph activity and the growth hormone axis. Core Peptides lists the product as a lyophilised powder with a stated purity of >99%.
Sermorelin is a synthetic 29-amino-acid analogue of growth hormone-releasing hormone (GHRH), while GHRP-6 and GHRP-2 are synthetic growth hormone secretagogues associated with the growth hormone secretagogue receptor GHS-R1a. Research into these pathways provides a basis for examining how GHRH-receptor and GHS-R1a signalling can converge in pituitary somatotroph cells.
This product is intended solely for qualified research, laboratory, analytical and in-vitro applications. It is not intended for human or animal consumption, diagnosis, treatment or prevention of disease.
What Is Sermorelin & GHRP-6 & GHRP-2 Blend?
The Sermorelin & GHRP-6 & GHRP-2 Blend brings together three research peptides that have been investigated for their roles in growth hormone signalling. Each component has a different structure and receptor profile, allowing researchers to examine multiple signalling inputs within the same experimental framework.
The formulation contains:
- Sermorelin – 3mg: A 29-amino-acid GHRH analogue investigated primarily through the GHRH receptor.
- GHRP-6 – 3mg: A synthetic hexapeptide studied as a growth hormone secretagogue and GHS-R1a agonist.
- GHRP-2 – 3mg: A synthetic growth hormone secretagogue, also known as pralmorelin, investigated in relation to GHS-R1a signalling.
Core Peptides specifies the composition as 3mg of each peptide, giving a total product quantity of 9mg in a 1:1:1 ratio.
Sermorelin & GHRP-6 & GHRP-2 – Product Specifications
| Specification | Details |
|---|---|
| Product Name | Sermorelin & GHRP-6 & GHRP-2 Blend |
| Total Quantity | 9mg |
| Sermorelin | 3mg |
| GHRP-6 | 3mg |
| GHRP-2 | 3mg |
| Blend Ratio | 1:1:1 |
| Form | Lyophilised powder |
| Listed Purity | >99% |
| Sermorelin Alternative Name | GRF 1-29 NH2 |
| GHRP-2 Alternative Name | Pralmorelin |
| GHRP-6 Alternative Names | SKF-110679; growth hormone-releasing hexapeptide |
| SKU | Sermorelin-GHRP-6-GHRP-2-9mg |
| Intended Use | Research, laboratory and analytical purposes |
The above product composition and presentation are based on the current Core Peptides product listing.
What Is Sermorelin?
Sermorelin is a synthetic peptide consisting of 29 amino acids and represents a shortened form of endogenous human growth hormone-releasing hormone. It is commonly identified as GHRH(1-29)-NH2 or GRF 1-29 NH2.
Research has investigated Sermorelin primarily through its interaction with the GHRH receptor on pituitary somatotroph cells. GHRH receptor activation is associated with intracellular signalling involving cyclic AMP (cAMP) and protein kinase A (PKA), pathways that participate in growth hormone synthesis and secretion.
Its defined peptide sequence makes Sermorelin a useful research compound for investigating the relationship between GHRH receptor activation and pituitary growth hormone responses.
What Is GHRP-6?
GHRP-6 is a synthetic hexapeptide that has been investigated as a growth hormone secretagogue. It is associated with the growth hormone secretagogue receptor type 1a (GHS-R1a), which is also known as the ghrelin receptor.
GHRP-6 does not share structural homology with ghrelin, but research indicates that it can activate GHS-R1a and influence signalling processes associated with growth hormone secretion from pituitary somatotrophs.
For laboratory researchers, GHRP-6 provides a model for examining GHS-R1a-mediated signalling separately from the GHRH receptor pathway.
What Is GHRP-2?
GHRP-2 is another synthetic growth hormone secretagogue and is also known as pralmorelin. Like GHRP-6, it has been studied in relation to the GHS-R1a receptor and its downstream signalling pathways.
GHRP-2 and GHRP-6 are structurally different synthetic hexapeptides, but both have been investigated for their ability to activate GHS-R1a and influence pituitary growth hormone release.
How Does the Three-Peptide Blend Work in Research?
The primary scientific interest in this blend comes from its combination of GHRH-receptor stimulation and GHS-R1a stimulation.
Sermorelin primarily represents the GHRH side of the signalling system, while GHRP-6 and GHRP-2 provide two different research ligands associated with the GHS-R1a pathway. This makes the blend relevant to investigations of receptor convergence and pituitary secretagogue responses.
Research cited by Core Peptides suggests that simultaneous activation of GHRH and GHS-R1a pathways can produce combined or potentially synergistic effects on growth hormone secretion under particular experimental conditions.
Importantly, most historical combination studies have examined GHRP-2 or GHRP-6 alongside full-length GHRH rather than this exact three-peptide formulation. Therefore, findings from individual studies should not automatically be attributed to the complete blend.
Sermorelin & GHRP-6 & GHRP-2 and Pituitary Research
The pituitary gland contains specialised cells called somatotrophs that produce and release growth hormone. These cells are an important model for studying the interaction between GHRH and growth hormone secretagogue pathways.
Sermorelin research focuses on activation of the GHRH receptor, while GHRP-6 and GHRP-2 research focuses on GHS-R1a. Because both receptor systems can influence somatotroph activity, the three-peptide blend provides a framework for examining multiple inputs simultaneously.
Potential laboratory endpoints can include:
- Growth hormone secretion.
- Receptor activation.
- Intracellular cAMP signalling.
- Intracellular calcium mobilisation.
- Protein kinase activity.
- Secretory-pulse characteristics.
- Downstream IGF-1 signalling.
GHRH Receptor Signalling and Sermorelin
Sermorelin is studied primarily through the GHRH receptor, a G-protein-coupled receptor found on pituitary somatotroph cells.
Research has associated activation of this receptor with intracellular messenger systems involving adenylate cyclase, cyclic AMP and protein kinase A. These signalling mechanisms can influence the cellular machinery responsible for growth hormone synthesis and release.
This pathway makes Sermorelin useful for research investigating the upstream regulation of pituitary GH secretion.
GHS-R1a Signalling and GHRP-2 & GHRP-6
GHS-R1a is a growth hormone secretagogue receptor that also responds to ghrelin. GHRP-2 and GHRP-6 have been studied as synthetic ligands of this receptor.
Research cited on the Core Peptides product page describes a signalling cascade involving phospholipase C (PLC), cleavage of PIP2 into IP3 and DAG, protein kinase C activation and calcium mobilisation. These intracellular processes may contribute to growth hormone release from pituitary cells.
Studying these pathways alongside Sermorelin-mediated GHRH receptor signalling allows researchers to examine how different signalling cascades interact.
Sermorelin, GHRP-6 & GHRP-2 and Growth Hormone Research
Growth hormone secretion is naturally pulsatile and is influenced by multiple endocrine signals. Laboratory studies involving Sermorelin, GHRP-6 and GHRP-2 have investigated how these compounds affect GH concentrations and secretory patterns.
Research cited by Core Peptides reports that Sermorelin can increase growth hormone output in selected experimental settings, while GHRP-2 and GHRP-6 have also been associated with short-term GH peaks.
The magnitude of an observed response varies according to the experimental model, peptide, concentration, timing, subject characteristics and study design. Consequently, individual study results should be considered within their original scientific context.
Research Into Combined Signalling
One of the most relevant research questions for this blend is whether simultaneous activation of GHRH and GHS-R1a pathways can produce a greater response than activating either pathway independently.
Several experimental studies cited by Core Peptides have reported enhanced growth hormone responses when GHRH and GHRP compounds were administered together. For example, research involving GHRP-6 and full-length GHRH has reported greater GH responses with the combination than with either peptide alone. Similar observations have been reported for GHRP-2 combined with GHRH.
These studies provide a scientific rationale for investigating combined receptor stimulation, although they do not establish that every Sermorelin, GHRP-6 and GHRP-2 formulation will produce the same result.
Sermorelin & GHRP-6 & GHRP-2 and IGF-1 Research
Insulin-like growth factor-1 (IGF-1) is an important downstream component of the growth hormone axis. Research involving GH secretagogues has therefore examined IGF-1 alongside growth hormone responses.
The Core Peptides product references research in which Sermorelin and GHRP-2 were associated with changes in IGF-1 under specific experimental conditions. It also cites research involving the combination of Sermorelin, GHRP-2 and GHRP-6 that observed an increase in IGF-1 from baseline measurements.
Because these studies used different experimental designs and cannot always isolate the contribution of each peptide, the findings are best considered evidence of research interest rather than proof of a specific effect attributable to this exact blend.
Potential Research Applications
Qualified laboratories may investigate Sermorelin & GHRP-6 & GHRP-2 Blend – 9MG in several areas of peptide and endocrine research, including:
- GHRH receptor research.
- GHS-R1a receptor research.
- Pituitary somatotroph studies.
- Growth hormone secretion research.
- GH secretory-pulse investigations.
- GH/IGF-1 axis research.
- Receptor cross-talk studies.
- cAMP and PKA signalling research.
- PLC, PKC and calcium signalling studies.
- Comparative peptide research.
- Structure–activity relationship studies.
- Endocrine physiology research.
Research Interest in GHRP-2 vs GHRP-6
Although GHRP-2 and GHRP-6 are both classified as growth hormone secretagogues and are associated with GHS-R1a, they are distinct peptide molecules. Researchers may therefore use both compounds to compare how structurally different ligands affect the same receptor system.
Including both GHRP-2 and GHRP-6 in the same research formulation creates an opportunity to investigate whether different GHS-R1a ligands produce distinguishable signalling profiles when evaluated alongside a GHRH analogue.
Such comparisons can be relevant to studies of receptor pharmacology, intracellular signalling and peptide structure–function relationships.
Sermorelin & GHRP-6 & GHRP-2 Chemical Information
| Property | Sermorelin | GHRP-6 | GHRP-2 |
|---|---|---|---|
| Common Name | Sermorelin | GHRP-6 | GHRP-2 |
| Alternative Name | GRF 1-29 NH2 | SKF-110679 | Pralmorelin |
| Classification | GHRH analogue | Growth hormone secretagogue | Growth hormone secretagogue |
| Sequence Length | 29 amino acids | 6 amino acids | 6 amino acids |
| Quantity in Blend | 3mg | 3mg | 3mg |
| Blend Ratio | 1:1:1 | ||
Core Peptides identifies the three components and their alternative names on the product listing.
Why Choose Sermorelin & GHRP-6 & GHRP-2 Blend – 9MG?
This research blend provides a convenient formulation containing three established peptide research compounds associated with growth hormone signalling.
- 9mg total peptide: Contains 3mg of each peptide.
- 1:1:1 composition: Provides equal quantities of Sermorelin, GHRP-6 and GHRP-2.
- >99% listed purity: The supplier lists the product with greater than 99% purity.
- Lyophilised format: Supplied as a dry peptide preparation for appropriate research handling.
- Multiple signalling pathways: Combines a GHRH analogue with two GHS-R1a research peptides.
- Established research background: All three peptides have been investigated in growth hormone and endocrine research.
Analytical Testing of Peptide Blends
Research laboratories may use analytical techniques to confirm peptide identity and assess purity. Depending on the experimental requirements, methods can include:
- High-performance liquid chromatography (HPLC) for chromatographic purity analysis.
- Mass spectrometry for molecular-mass and identity confirmation.
- Peptide mapping where appropriate for structural characterisation.
- Receptor-binding assays for peptide–receptor interaction research.
- Cell-based assays for investigating biological activity.
- Immunoassays for measuring experimental GH or IGF-1 responses.
Researchers should review the applicable batch-specific Certificate of Analysis and supplier documentation before using research material in laboratory experiments.
Laboratory Handling and Storage
Sermorelin & GHRP-6 & GHRP-2 Blend – 9MG is supplied as a lyophilised powder. Laboratories should follow the supplier’s current storage instructions and their own validated procedures for handling peptide research materials.
- Keep the product in its original labelled container.
- Protect the lyophilised material from unnecessary moisture exposure.
- Follow the supplier’s recommended storage conditions.
- Minimise unnecessary temperature fluctuations.
- Use appropriate laboratory protective equipment.
- Follow institutional procedures for handling and disposal.
- Consult batch-specific documentation before experimental use.
Storage requirements can depend on formulation, packaging and the intended experimental protocol. The supplier’s current technical documentation should always take precedence.
Frequently Asked Questions About Sermorelin & GHRP-6 & GHRP-2 Blend – 9MG
What is Sermorelin & GHRP-6 & GHRP-2 Blend?
It is a research peptide blend containing 3mg Sermorelin, 3mg GHRP-6 and 3mg GHRP-2, for a total of 9mg. The supplier lists it as a lyophilised powder with greater than 99% purity.
What is the ratio of the three peptides?
The blend contains the three peptides in a 1:1:1 ratio, with 3mg of each component.
What is Sermorelin?
Sermorelin is a synthetic 29-amino-acid analogue of GHRH. It is primarily researched in relation to GHRH receptor signalling and pituitary growth hormone regulation.
What is GHRP-6?
GHRP-6 is a synthetic hexapeptide investigated as a growth hormone secretagogue and in relation to the GHS-R1a receptor.
What is GHRP-2?
GHRP-2, also known as pralmorelin, is a synthetic hexapeptide researched for its activity at the growth hormone secretagogue receptor GHS-R1a.
Why are these three peptides combined?
The combination allows researchers to investigate a GHRH analogue alongside two distinct growth hormone secretagogue peptides. This can be useful for examining interactions between GHRH-receptor and GHS-R1a signalling pathways.
Does the combination have a synergistic effect?
Research involving GHRH and GHRP compounds has reported enhanced growth hormone responses when the pathways are stimulated together in certain experimental models. However, most studies have not examined this exact three-peptide formulation, so the findings should not be treated as proof of a universal synergistic effect.
What is the purity of the 9MG blend?
Core Peptides currently lists the product with a purity of >99%.
What form is the blend supplied in?
The product is supplied as a lyophilised powder.
What research areas are associated with this blend?
Research areas include growth hormone secretion, pituitary somatotroph biology, GHRH receptor signalling, GHS-R1a signalling, GH/IGF-1 research and peptide receptor interactions.
Is the product intended for human use?
No. Core Peptides states that its products are sold for research, laboratory or analytical purposes only and are not intended for human consumption.
Can this product be used for bodybuilding or athletic performance?
No. This product should not be marketed or used for self-administration, bodybuilding or athletic performance. It is intended exclusively for appropriate research and laboratory applications.
Sermorelin & GHRP-6 & GHRP-2 Blend – 9MG Research Summary
Sermorelin & GHRP-6 & GHRP-2 Blend – 9MG combines three research peptides in equal quantities: 3mg Sermorelin, 3mg GHRP-6 and 3mg GHRP-2. The formulation is supplied as a lyophilised powder and is listed by Core Peptides with greater than 99% purity.
Sermorelin provides a research model for GHRH receptor signalling, while GHRP-6 and GHRP-2 are associated with GHS-R1a. Studying these pathways together can help researchers investigate the regulation of pituitary somatotrophs, growth hormone secretion, intracellular signalling and downstream components of the GH/IGF-1 axis.
Existing research suggests that simultaneous activation of GHRH and GHS-R1a pathways may enhance growth hormone responses in certain experimental models. However, much of the available evidence concerns combinations involving full-length GHRH rather than the precise three-peptide formulation described here. Findings should therefore be interpreted cautiously and within the context of the original experimental evidence.
Research-Use Disclaimer
Sermorelin & GHRP-6 & GHRP-2 Blend – 9MG is intended solely for qualified research, laboratory, analytical and in-vitro experimental purposes. It is not intended for human or veterinary consumption, self-administration, diagnosis, treatment, cure or prevention of any disease.
References to growth hormone, IGF-1, endocrine signalling, anabolic pathways or other biological effects describe areas of scientific investigation and should not be interpreted as established clinical benefits or medical advice.
Researchers should review the applicable Certificate of Analysis, product documentation, safety information and relevant legislation before working with this material. Handling, storage and disposal should be performed by appropriately trained personnel using suitable laboratory procedures.
For research use only. Human and animal consumption prohibited.
Product specifications and availability should be verified against the current supplier listing before publication or purchase.
Be the first to review “Sermorelin & GHRP-6 & GHRP-2 Blend – 9MG”
Related products
Peptides for Sale
Peptides for Sale
Peptides for Sale
Peptides for Sale
Peptides for Sale
Peptides for Sale
Peptides for Sale
Peptides for Sale
Reviews
There are no reviews yet.